Literature DB >> 11267290

Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes.

B D Kahan1, K L Napoli, J Podbielski, I Hussein, S H Katz, C T Van Buren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267290     DOI： 10.1016/s0041-1345(00)02476-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients.

Authors:  C Dansirikul; S B Duffull; R G Morris; S E Tett
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

2.  Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.

Authors:  Nassim Djebli; Annick Rousseau; Guillaume Hoizey; Jean-Philippe Rerolle; Olivier Toupance; Yann Le Meur; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  A Bayesian approach for population pharmacokinetic modelling of sirolimus.

Authors:  Chantaratsamon Dansirikul; Raymond G Morris; Susan E Tett; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

Review 4.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.